Vaccine disputes may harm pharmaceutical industry's reputation

Vaccine disagreements may risk breathing new life into the pharmaceutical industry skepticism of yonder years, according to MedWatch's sources.

Photo: Pedro Nunes/Reuters/Ritzau Scanpix

Recent conflicts between the EU and coronavirus vaccine-producing pharmaceutical companies can seriously harm the industry's reputation, according to ad company Mensch's partner, Frederik J. Preisler, and Communications Advisor Sune Bang.

News of broken agreements, fewer vaccines than promised and production problems can quickly breathe life into the kind of skepticism towards the pharmaceutical industry that used to be more predominant, according to the sources.

Read the whole article

Get 14 days free access.

No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Latest news

See all jobs